Redhill Biopharma News

Redhill Biopharma | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 8 09:32 ET

Redhill Biopharma | 20-F: Registration statement / Annual report / Transition report

Apr 8 09:27 ET

Redhill Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 4 16:09 ET

Redhill Biopharma | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 3 07:02 ET

Redhill Biopharma | 424B5: Prospectus

Apr 2 16:12 ET

Redhill Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 2 07:04 ET

Redhill Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 21 16:08 ET

Redhill Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 20 16:43 ET

Redhill Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 14 16:08 ET

Redhill Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 11 07:06 ET

Redhill Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 5 07:02 ET

Redhill Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 20 16:10 ET

Redhill Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 20 07:03 ET

Redhill Biopharma | 424B3: Prospectus

Feb 16 08:56 ET

Redhill Biopharma | EFFECT: Others

Feb 16 06:06 ET

Redhill Biopharma | CORRESP: CORRESP

Feb 15 12:59 ET

Redhill Biopharma | UPLOAD: Others

Feb 14 12:59 ET

Redhill Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 13 16:07 ET

Redhill Biopharma | F-1: Registration statement for securities of certain foreign private issuers

Feb 9 16:27 ET

Redhill Biopharma | D: Filing D

Feb 5 08:02 ET